Ann Surg Oncol (2018) 25:1797–1798 https://doi.org/10.1245/s10434-018-6478-6 ED ITORIA L – PA NCREATI C TU MORS What is the Incidence of Malignancy in Resected IPMN? An Analysis of Over 100 U.S. Institutions in a Single Year Carl R. Schmidt, MD, FACS and Jordan Cloyd, MD Ohio State University Wexner Medical Center, Columbus, OH In this issue of the Annals of Surgical Oncology, Dr. intervention for these patients even at the time of low-grade Rym El Khoury and colleagues describe the current inci- dysplasia might in fact be preferred, if we could accurately dence of high-risk intraductal papillary mucinous predict which 10% will progress. neoplasms (IPMN) among pancreatic resections performed In addition to reporting on the incidence of malignancy in the United States. They use the American College of among resected IPMNs, the authors attempt to identify Surgeons National Surgical Quality Improvement Project preoperative risk factors for high-risk pathology. This is (ACS-NSQIP) dataset to address this question from a limited, because some important factors are unavailable in population-based perspective. With data available from the ACS-NSQIP database (e.g., imaging characteristics of more than 100 hospitals, approximately 10% of all pan- the lesion). They do demonstrate that jaundice and weight creas resections in
Annals of Surgical Oncology – Springer Journals
Published: Apr 19, 2018
It’s your single place to instantly
discover and read the research
that matters to you.
Enjoy affordable access to
over 18 million articles from more than
15,000 peer-reviewed journals.
All for just $49/month
Query the DeepDyve database, plus search all of PubMed and Google Scholar seamlessly
Save any article or search result from DeepDyve, PubMed, and Google Scholar... all in one place.
Get unlimited, online access to over 18 million full-text articles from more than 15,000 scientific journals.
Read from thousands of the leading scholarly journals from SpringerNature, Elsevier, Wiley-Blackwell, Oxford University Press and more.
All the latest content is available, no embargo periods.
“Hi guys, I cannot tell you how much I love this resource. Incredible. I really believe you've hit the nail on the head with this site in regards to solving the research-purchase issue.”Daniel C.
“Whoa! It’s like Spotify but for academic articles.”@Phil_Robichaud
“I must say, @deepdyve is a fabulous solution to the independent researcher's problem of #access to #information.”@deepthiw
“My last article couldn't be possible without the platform @deepdyve that makes journal papers cheaper.”@JoseServera